Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion. | Biochim Biophys Acta;1831(4): 719-25, 2013 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion.

Serhan, Nizar; Cabou, Cendrine; Verdier, Céline; Lichtenstein, Laeticia; Malet, Nicole; Perret, Bertrand; Laffargue, Muriel; Martinez, Laurent O.

Affiliation

Serhan N; INSERM, UMR 1048, Institut de Maladies Métaboliques et Cardiovasculaires, Toulouse, 31000, France.

Biochim Biophys Acta ; 1831(4): 719-25, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23266391

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Acids and Salts / Receptors, Purinergic P2 / Cholesterol, HDL / Liver Limits: Animals Language: En Journal: Biochim Biophys Acta Year: 2013 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bile Acids and Salts / Receptors, Purinergic P2 / Cholesterol, HDL / Liver Limits: Animals Language: En Journal: Biochim Biophys Acta Year: 2013 Document type: Article Affiliation country: Country of publication: